Latest News for: rna editing

Edit

Fosun Pharma Announces 2024 Annual Results

Knoxville Daily Sun 26 Mar 2025
... small molecule development, while collaborating with industry funds to pioneer next-generation modalities such as radiopharmaceuticals, RNA therapeutics, gene editing, and AI-powered drug discovery.
Edit

Scientists unravel RNA-editing mystery, paving way for next-gen cancer treatments

Interesting Engineering 17 Mar 2025
“These insights pave the way for novel therapeutic strategies targeting ADAR1-related diseases.” RNA editing mechanism of ADAR1 ... strategies that leverage its RNA-editing capabilities,” Gao said.
Edit

RNA Therapies Clinical Trials and Pipeline 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approval, ...

GetNews 17 Mar 2025
In June 2024, Ascidian Therapeutics announced a research collaboration and licensing agreement with Roche for the discovery and development of RNA exon editing therapeutics targeting neurological diseases.
Edit

New study reveals a simple genetic approach to tackle aggressive cancers

Hindustan Times 17 Mar 2025
RNA splicing's role in cancer growth ... Interestingly, when researchers completely removed TRA2b proteins using CRISPR gene editing, tumours continued to grow--suggesting that targeting the RNA rather than the protein could be a more effective approach.
Edit

Retinitis Pigmentosa Pipeline 2024: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight ...

GetNews 14 Mar 2025
In July 2024, South Korean biopharmaceutical company Rznomics is preparing to initiate a Phase I/IIa clinical trial for its RNA editing therapy, RZ-004, aimed at treating retinitis pigmentosa.
Edit

ProQR Announces Year End 2024 Operating and Financial Results

Pharmiweb 13 Mar 2025
Axiomer™ ADAR-mediated RNA editing ... “As we continue to advance our Axiomer ADAR-mediated RNA editing platform and pipeline, ProQR is entering a pivotal phase of growth and innovation,” said Daniel A.
  • 1
×